188 related articles for article (PubMed ID: 7922761)
1. [Red-cell sodium-lithium countertransport in patients with IgA nephrology and renal hypertension].
Chen YD; Zheng FL; Wen LR
Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):214-7, 254. PubMed ID: 7922761
[TBL] [Abstract][Full Text] [Related]
2. Effects of atorvastatin on red-blood cell Na(+)/Li(+) countertransport in hyperlipidemic patients with and without hypertension.
Kosmidou MS; Hatzitolios AI; Adamidou A; Giannopoulos S; Raikos N; Parharidis G; Milionis HJ
Am J Hypertens; 2008 Mar; 21(3):303-9. PubMed ID: 18202666
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte sodium-lithium countertransport in primary and renal hypertension: relation to family history.
Carr SJ; Thomas TH; Wilkinson R
Eur J Clin Invest; 1989 Feb; 19(1):101-6. PubMed ID: 2499456
[TBL] [Abstract][Full Text] [Related]
4. Erythrocyte sodium-lithium countertransport and proliferative diabetic retinopathy.
Lopes de Faria JM; Silveira LA; Morgano M; Pavin EJ; Lopes de Faria JB
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1482-5. PubMed ID: 10798666
[TBL] [Abstract][Full Text] [Related]
5. Sodium-lithium countertransport activity in red blood cells of patients with IgA nephropathy.
Boero R; Fabbri A; Degli Esposti E; Guarena C; Forneris G; Lucatello A; Sturani A; Quarello F; Fusaroli M; Piccoli G
Am J Kidney Dis; 1993 May; 21(5 Suppl 2):61-5. PubMed ID: 8494021
[TBL] [Abstract][Full Text] [Related]
6. Red blood cell sodium-lithium countertransport in patients with essential and renal hypertension.
Petrov VV; Arabidze CG; Levitsky DO; Eliseev AO; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Mar; 16(2):153-7. PubMed ID: 8007744
[TBL] [Abstract][Full Text] [Related]
7. Increased sodium-lithium countertransport activity in red cells of IgA nephropathy patients.
Boero R; Degli Esposti E; Fabbri A; Guarena C; Forneris G; Quarello F; Fusaroli M; Piccoli G
Kidney Int; 1991 Dec; 40(6):1118-22. PubMed ID: 1762312
[TBL] [Abstract][Full Text] [Related]
8. [Sodium and lithium transport and steroid hormones of the adrenal glands].
Eliseev AO; Petrov VV; Chikhladze NM; Domba GIu; Kaĭkov MI
Sov Med; 1989; (1):24-9. PubMed ID: 2718020
[TBL] [Abstract][Full Text] [Related]
9. [Erythrocyte sodium-lithium countertransport in diabetic children: 12 months development and relationship with familial hypertension].
Guarena C; Boero R; Quarello F; Cerruti F; Rolando B; Sacchetti C; Rosati C; Iadarola G; Piccoli G
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1205-7. PubMed ID: 1482260
[TBL] [Abstract][Full Text] [Related]
10. Nonlinear relationship between erythrocyte sodium-lithium countertransport and blood pressure in man.
Petrov VV; Britov AN; Levitsky DO; Minchenko BI; Konstantinov EN; Svidersky VD; Novikov ID; Grishenkov EA; Lijnen PJ
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):661-6. PubMed ID: 7746028
[TBL] [Abstract][Full Text] [Related]
11. Elevation of red cell sodium-lithium countertransport in hyperlipidemias.
Corrocher R; Steinmayr M; Ruzzenente O; Brugnara C; Bertinato L; Mazzi M; Furri C; Bonfanti F; De Sandre G
Life Sci; 1985 Feb; 36(7):649-55. PubMed ID: 3968981
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of sodium-lithium countertransport in normotensive and hypertensive subjects.
Siebers RW; Maling TJ
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S59-61. PubMed ID: 1708027
[TBL] [Abstract][Full Text] [Related]
13. Abnormal sodium-lithium countertransport kinetics in immunoglobulin A nephropathy patients and the families: association with hypertension.
Ho KL; Rutherford PA; Thomas TH; Wilkinson R
Am J Kidney Dis; 1996 Mar; 27(3):334-40. PubMed ID: 8604701
[TBL] [Abstract][Full Text] [Related]
14. Abnormal kinetics of erythrocyte sodium lithium countertransport in patients with diabetic nephropathy in Thailand.
Vareesangthip K; Panthongdee W; Shayakul C; Nitiyanant W; Ong-Aj-Yooth L
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S48-53. PubMed ID: 17044454
[TBL] [Abstract][Full Text] [Related]
15. [Increased red-cell sodium-lithium countertransport activity and urinary 11-dehydrothromboxane B2 during pregnancy].
Yoshimura T; Okazaki T; Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):153-8. PubMed ID: 1545169
[TBL] [Abstract][Full Text] [Related]
16. Sodium-lithium countertransport is not a marker of proximal tubular sodium clearance.
Maling TJ; Siebers RW
J Cardiovasc Pharmacol; 1990; 16 Suppl 7():S50-1. PubMed ID: 1708024
[TBL] [Abstract][Full Text] [Related]
17. [Clinical value of determining Na-Li countertransport in the diagnosis of arterial hypertension associated with minor urinary syndrome].
Eliseev AO; Arabidze GG; Petrov VV; Kukharchuk VV; Kaĭkov MI
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1988; 11(1):37-40. PubMed ID: 3401339
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Na-Li countertransport: a marker of inherited susceptibility to type 2 diabetes.
Vaccaro O; Cuomo V; Trevisan M; Cirillo M; Panarelli W; Laurenzi M; Mancini M; Riccardi G;
Int J Epidemiol; 2005 Oct; 34(5):1123-8. PubMed ID: 16087689
[TBL] [Abstract][Full Text] [Related]
19. G-protein beta3-subunit gene variant, blood pressure and erythrocyte sodium/lithium countertransport in essential hypertension.
Poch E; González-Núñez D; Compte M; De la Sierra A
Br J Biomed Sci; 2002; 59(2):101-4. PubMed ID: 12113397
[TBL] [Abstract][Full Text] [Related]
20. Thiol protein defect in sodium-lithium countertransport in subset of essential hypertension.
Mead P; Wilkinson R; Thomas TH
Hypertension; 1999 Dec; 34(6):1275-80. PubMed ID: 10601130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
